Nicole Borsje | IR |
Ming Hsieh | CEO |
Brandon Perthuis | Chief Commercial Officer |
Larry Weiss | Chief Medical Officer |
Paul Kim | CFO |
Kevin DeGeeter | Oppenheimer |
David Westenberg | Piper Sandler |
Good day and welcome to the Q1 2022 Fulgent Genetics Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Nicole Borsje. Please go ahead, ma’am.
Thanks.